Doripenem MICs andompK36Porin Genotypes of Sequence Type 258, KPC-Producing Klebsiella pneumoniae May Predict Responses to Carbapenem-Colistin Combination Therapy among Patients with Bacteremia

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

(2014) George L. Daikos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treating infections caused by carbapenemase-producing Enterobacteriaceae

(2014) L.S. Tzouvelekis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Epidemiology and Molecular Characterization of Bacteremia Due to Carbapenem-ResistantKlebsiella pneumoniaein Transplant Recipients

(2013) C. J. Clancy et al.   AMERICAN JOURNAL OF TRANSPLANTATION

New β-lactam-β-lactamase inhibitor combinations in clinical development

(2013) David M. Shlaes   Annals of the New York Academy of Sciences

Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems

(2013) Jae H. Hong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutations of theompK36Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin

(2013) Cornelius J. Clancy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens

(2012) Zubair A. Qureshi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae

(2012) Meredith G. Jernigan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

(2012) M. Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Meropenem by Continuous Infusion to Treat a Patient with a Blakpc-2-Positive Klebsiella pneumoniae Blood Stream Infection

(2011) Vanessa P. Ho et al.   Surgical Infections

Pharmacokinetic–pharmacodynamic modeling to support doripenem dose regimen optimization for critically ill patients

(2009) Scott A. Van Wart et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE